|
|
||||||||
Department of Thoracic Surgery, First Affiliated Hospital, Fujian Medical University, Fuzhou, China
Accepted for publication January 18, 2008.
* Address correspondence to Dr Li, General Thoracic Surgery Department, First Affiliated Hospital, Fujian Medical University, Fuzhou City, 350005, China (Email: lixu1967{at}hotmail.com).
| Abstract |
|---|
|
|
|---|
Methods: Two hundred thirty-two patients with primary palmar hyperhidrosis were randomly allocated to either a T3 sympathectomy treatment, called group T3, or a T2–4 sympathetic treatment, called group T2–4. The patients underwent bilateral sympathetic ablation at corresponding levels. All patients were followed up and evaluated for comparison of symptom resolution, postoperative complication, levels of satisfaction, and severity of compensatory sweating between the two groups.
Results: Sex, age, family history, and distribution of sweating were similar in both groups. The postoperative complications were minor, and Horner's syndrome was not detected in either group. The frequency of mild and moderate compensatory sweating was not significantly different between the two groups, but the incidence of severe compensatory sweating was significantly lower after T3 sympathectomy (3% versus 10%). As for satisfaction rate, group T3 was superior to group T2–4 (96.6% versus 89.6%). The rate of symptom resolution was 100%, and no recurrence was found in either group.
Conclusions: The single-level sympathetic denervation under thoracoscopy is a safe and effective procedure to treat primary palmar hyperhidrosis. This method reduces the incidence of severe compensatory sweating postoperatively without compromising the patient's satisfaction.
| Introduction |
|---|
|
|
|---|
| Patients and Methods |
|---|
|
|
|---|
Enrollment and Randomization
The trial was approved by the Ethics Committee of Fujian Medical University (No. 2003037). Prerandomization procedures for eligibility of patients consist of a careful evaluation of inclusion and exclusion criteria (Table 1) and collection of an informed consent. Additionally, a detailed medical history including demographic data and clinical status was documented. Randomization was performed following a computer-generated list. Patients were allocated to T2–4 denervation or T3 denervation by using sequentially numbered sealed envelopes with information disclosing the type of treatment to be applied. Recruitment began on June 2, 2003, and by the end of June 2006, a total of 232 patients had been randomly assigned, 115 patients to receive T2–4 denervation and 117 patients to receive T3 denervation.
|
Follow-Up and Data Collection
All study patients were scheduled for follow-up either by visits or through the mail at 1 and 12 months after randomization. Patients were required to fill out a detailed questionnaire (Table 2). The data collected include resolution of symptoms, postoperative complications, the severity of compensatory sweating, levels of satisfaction with procedure, and incidence of symptom recurrence. The resolution of symptoms is a combination of completely dry and visible improvement.
|
2 test. All p values less than 0.05 were considered statistically significant. | Results |
|---|
|
|
|---|
|
|
2 = 5.63 p < 0.05). Resolution rates of accompanying plantar and axillary hyperhidrosis were between 57% and 75% (Table 6), and there was no significant difference between the two groups. No recurrent symptoms were observed in our study.
|
|
2 = 1.40 p > 0.05 and
2 = 0.32 p > 0.05). However, it is seen that severe compensatory sweating was significantly lower in group T3 (
2 = 4.47 p < 0.05).
|
| Comment |
|---|
|
|
|---|
A variety of different surgical procedures have been used over time with varying results [2–9]. At present, there is no consensus for surgical procedure. The diversity of these surgical techniques focus on the following aspects: first, sympathectomy or sympathictomy (ie, resection or ablation); second, sympathetic ganglion denervation or sympathetic chain denervation; third, the extent of sympathetic denervation (ie, single-level denervation or multiple-level denervation); fourth, which level is the best level to ablate; and last, how to deal with Kuntz fiber.
The term "sympathectomy" historically referred to extirpation or destruction of the sympathetic ganglia and chain, and the term "sympathicotomy" meant severing the sympathetic chain. Modern day usage by the lay public has extended the term thoracic sympathectomy to include the latter operative technique as well because, from a functional perspective, the two technical approaches produce the same desired effects, that is, teh term "sympathectomy" is often used synonymously with "sympathicotomy." Comparing the two procedures, the mean operative time for a sympathicotomy has been shown to be significantly less than that of sympathectomy. Resection requires almost twice the time needed for ablation [10]. Furthermore, sympathicotomy is technically easier than sympathectomy, which is another important reason why the former is preferred in our study; although early in some experience, a standard three-port sympathectomy with resection of the sympathetic chain was employed. Nowadays, most studies [5–9] employ the sympathicotomy, allowing for fewer incisions and less external and internal tissue trauma, while producing equivalent clinical results.
When performing sympathectomy, some clinical series removed the sympathetic ganglion [4, 11]; others transected the sympathetic chain [7, 8]. As both procedures produced similar postoperative outcome, these studies placed little emphasis on the distinction between them. In our study, we prefer the "chain" ablation instead of "ganglion" transection, as the former is technically easier and causes fewer iatrogenic injuries. Many surgical anatomy studies [12, 13] also indicate that thoracic the ganglion was consistently located in the intercostals space, whereas the sympathetic chain lies against the corresponding costal head and is more superficial and visualized easier than ganglion. Other anatomical factors such as the superior intercostal vein are also considered as a cause of an unsuccessful procedure during ganglionectomy. Our clinical experience demonstrates that the arrangement of the right superior intercostal vein and its tributaries is more closely surgically relevant to the sympathetic ganglion than to the sympathetic chain. Injury to this vein may cause troublesome bleeding that compromises dissection of the sympathetic chain. In our series, simple ablation of the sympathetic chain at the corresponding costal head is preferable. The cautery transection is limited to that part of the nerve directly overlying the costal head, avoiding the intercostal space and its neurovascular structure.
Compensatory sweating is the most common and distressing complication for sympathectomy. It is characterized by the postoperative appearance of excessive perspiration in regions of the body where it had not been previously observed. Different studies have had controversial results in terms of this side effect [5–9]. The incidence of compensatory sweating depends on climatic conditions and emotional stress, and is higher in warm and humid locations. Compensatory sweating also will be greatly reduced as time goes by, and remains stable 6 months after surgery [5, 6]. At present, there is no consensus for the definition and classification of compensatory sweating. We defined severe compensatory sweating as follows: first, under the daily activity condition, the need to change underwear more than twice a day [14]; second, the timing of the diagnosis for compensatory sweating is 12 months after surgery.
The pathogenesis of compensatory sweating is obscure, and the proper procedure to resolve this problem has not been determined. It is postulated that this phenomenon is caused by a temperature-regulating compensatory mechanism in the body and is correlated with the extent of sypathectomy. That is, the greater the number of glands removed from thermoregulatory control, the greater is the response anticipated from the remaining glands. The main aim of our randomized clinical trial presented here was to find out whether there is an association between the extent of sympathectomy and the occurrence and severity of compensatory sweating. Our results revealed that the incidences of mild and moderate compensatory sweating in T3 and T2–4 sympathectomy were not significantly different, but severe compensatory sweating is signigicantly reduced in T3 sympathectomy (3% versus 10%). These results are similar to those of previous studies in which the authors reported a low incidence of compensatory sweating after T3 sympathectomy [7, 15].
Traditionally, the second thoracic ganglion is considered to be the key ganglion for sympathetic denervation of upper extremity [16]. In 2001, Lin and Telaranta [17] reported that compensatory sweating was less prevalent among patients who underwent T3 and T4 ganglion resection than among patients with T2 ganglion ablation. They theorized that the higher the interruption or resection in the sympathetic chain was performed, the more afferent fiber responsible for inhibiting sudoresis would be damaged, thereby causing a considerable increase in quantity and severity of compensatory sweating. After that, many studies [7–9, 11] have shown that preservation of the T2 ganglion may reduce the incidence of compensatory sweating. Presently, it seems that the T3 ganglion is the key ganglion for sympathetic denervation of the upper extremity, and ablation of the sympathetic chain at the third costal head is an optimum procedure for plamar hyperhidrosis.
Some authors [18, 19] have proposed that T4 sympathectomy or ramicotomy may decrease the incidence of compensatory sweating further. But in their study, the failure rate of symptom resolution was also increased. Our experience during sympathectomy procedures also indicates the T4 segment is not as important for sympathetic control of the hand as is T3. This is confirmed by lack of palmar skin temperature change after T4 ablation in some cases. Therefore, we recommend the carrying out of a prospective, randomized trial that compares T3 and T4 denervation in patients with palmar hyperhidrosis.
In our series, symptoms of palmar hyperhidrosis resolved in all patients without recurrence reported after 12 months of follow-up. The symptoms usually disappeared immediately after operation, and patients can confirm this in the recovery room. On the other hand, failure of symptom resolution can be attributable to various causes such as mistaken identification of the sympathetic level, incomplete ablation, or accessory nerve pathways (Kuntz fiber). An anatomic study [12] indicated that the accessory bypass nerve fiber directly connected the second or third or fourth ganglion to the brachial plexus. It was found in 34.9% (right) and 51.2% (left) of cadaver studies. When present, these fibers were a mean distance of 7.33 mm (range, 2.3 mm to 15.7 mm) lateral to the thoracic sympathetic chain. Therefore, in all sympathectomy procedures, we routinely extended the diathermy incision laterally for approximately 3 cm on the corresponding costa to include any accessory nerve fibers.
Complications were relatively rare and were minor in our series. The mean satisfaction rate was 93%, and no Horner's syndrome developed. Logically, the risk of developing Horner's syndrome could be expected to be lower in a very simplified sympathetic procedure. The interesting phenomenon of "rebound sweating" occurred in 3% of our patients. This obscure, transient excessive sweating of the target organ typically occurred on postoperative day 1 to 3, and lasted only about 1 day. The mechanism to explain this phenomenon is still not known.
In this randomized clinical trial, we endeavored to report the results of T3 and T2–4 thoracoscopic sympathectomy for treatment of primary palmar hyperhidrosis in one institution of Southeast China. From our results, we believe that simple T3 level sympathetic chain ablation is an optimum procedure for palmar hyperhidrosis. These findings could help us to reach a consensus on the standard operation for palmar hyperhidrosis surgery.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
A. Fiorelli, A. D'Aponte, R. Canonico, A. Palladino, G. Vicidomini, F. Limongelli, and M. Santini T2-T3 sympathectomy versus sympathicotomy for essential palmar hyperhidrosis: comparison of effects on cardio-respiratory function Eur J Cardiothorac Surg, September 1, 2012; 42(3): 454 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Low Invited Commentary Ann. Thorac. Surg., August 1, 2012; 94(2): 405 - 405. [Full Text] [PDF] |
||||
![]() |
R. J. Cerfolio, J. R. M. De Campos, A. S. Bryant, C. P. Connery, D. L. Miller, M. M. DeCamp, R. J. McKenna, and M. J. Krasna The Society of Thoracic Surgeons Expert Consensus for the Surgical Treatment of Hyperhidrosis Ann. Thorac. Surg., May 1, 2011; 91(5): 1642 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. de Lima, J.-C. Das-Neves-Pereira, J. R. M. de Campos, and F. B. Jatene Factors affecting long-term satisfaction after thoracic sympathectomy for palmar and plantar hyperhidrosis. Is the sudomotor reflex the only villain? Interact CardioVasc Thorac Surg, April 1, 2011; 12(4): 554 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, Y.-R. Tu, M. Lin, F.-C. Lai, J.-F. Chen, and H.-W. Miao Minimizing Endoscopic Thoracic Sympathectomy for Primary Palmar Hyperhidrosis: Guided by Palmar Skin Temperature and Laser Doppler Blood Flow Ann. Thorac. Surg., February 1, 2009; 87(2): 427 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Connery Invited Commentary Ann. Thorac. Surg., February 1, 2009; 87(2): 431 - 431. [Full Text] [PDF] |
||||
![]() |
T. Walles, G. Somuncuoglu, V. Steger, S. Veit, and G. Friedel Long-term efficiency of endoscopic thoracic sympathicotomy: survey 10 years after surgery Interact CardioVasc Thorac Surg, January 1, 2009; 8(1): 54 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Licht Invited Commentary Ann. Thorac. Surg., May 1, 2008; 85(5): 1751 - 1752. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |